December 02, 2015 –  The American Food and Drug Administration (FDA) just granted approval for Elotuzumab (Empliciti) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications. Elotuzumab (Empliciti) is a monoclonal …

Elotuzumab (Empliciti), a new immune-stimulating therapy to treat multiple myeloma has been approved Read more »

November 21, 2015 – During the last few days, the American Food and Drug Administration  (FDA) just extended the armamentarium in the fight against multiple myeloma by two new entries, namely Ixazomib (Ninlaro) and Daratumumab (Darzalex). Both drugs are intended to treat …

FDA extends armamentarium to treat multiple myeloma: Ixazomib (Ninlaro) and Daratumumab (Darzalex) approved Read more »